NeuroVision’s $10M in Financing to Support Potential Approach to Detecting Alzheimer’s Using Retinal Imaging

NeuroVision’s $10M in Financing to Support Potential Approach to Detecting Alzheimer’s Using Retinal Imaging
NeuroVision Imaging has raised $10 million in new funding through a Series B financing round, led by a $5 million investment from Wildcat Capital Management. The funds will support NeuroVision’s research on retinal imaging technology, a potential new approach to amyloid detection in Alzheimer’s disease (AD). A particular hallmark of Alzheimer’s is the buildup of amyloid

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *